A new study has investigated the effect and safety of Ozone Autohemotherapy combined with pharmacological therapy in Postherpetic Neuralgia (PHN).
Patients with Postherpetic Neuralgia suffer from persistent and severe breakthrough pain, which may arise from nerve changes due to virus infection or immune response.
PHN is one of the most common types of neuropathic pain (NP) syndrome and is characterized by pain. Patients who recover from herpes zoster rash may be afflicted with months and years of pain. Some studies have reported that compared with other types of pain, PHN is characterized by severe pain and severe harm to the patient’s quality of life.
In conclusion, the findings of this new study demonstrated that Ozone Autohemotherapy combined with pharmacological therapy was superior to isolated pharmacological therapy in the treatment of PHN and was an effective and safe way to relieve PHN.
National Center for Biotechnology Information, U.S. National Library of Medicine